StrIVeMD Wellness and Ketamine
- PRP Therapy
- IV Therapy
- Ketamine Therapy
- Migraine Treatment
- Peptide Therapy
Dublin, OH
stem cell therapy consult rooms in Dublin OH sit along US-33 / I-270 Dublin exits, Bridge Street District / Sawmill Road corridor, and Muirfield / Avery Road drive-time suites, more than spa calendars. Local stem cell therapy clinics pack cash-pay menus between orthopedics referrals and drive-time regenerative pitches aimed at metro and suburb patients alike. A neighboring suburb commute changes who books follow-up, not product sourcing math. This hub is Dublin OH listings, not Columbus core or Worthington paste.
Source tissue claims, processing methods, and follow-up imaging all change what you buy. A lobby claim of "stem cell cure" is marketing until you see the written protocol and consent language.
This hub lists Directory clinics for Dublin OH and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask what tissue source they use, how the product is processed, what FDA framing they give, what contraindications they screen, and what happens if outcomes do not match the brochure. Local freeways shape booking windows, not the underlying biology. Prefer plain risk talk and written consent. Use the national stem cell therapy Directory and Guide, then return here.
Before you trust badges and counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
Ohio cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Ohio for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Ohio hosts substantial academic regenerative medicine research at Case Western and Cleveland Clinic.
The FDA has issued warning letters to Ohio clinics offering stem cell and exosome therapies. The State Medical Board of Ohio has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The Ohio Attorney General has used the Consumer Sales Practices Act to pursue providers making unsupported clinical claims. Ohio's combination of academic IND-based research and direct-to-patient regenerative clinics produces a mixed compliance landscape.
Available here
Nationwide
Stem Cell Therapy clinics across the US